Brazil's Supreme Court ruled that scientists can conduct embryonic stem cell research, which holds the promise of curing Parkinson's disease, diabetes, and other diseases, but raises ethical concerns about the limits on human life. Advocates have said that a favorable Supreme Court ruling could make Brazil Latin America's leader in stem cell research.